(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

A. Collignon, C. Houillier, G. Ahle, O. Chinot, S. Choquet, A. Schmitt, P. Agape, C. Soussain, K. Hoang-Xuan, Emeline Tabouret

ABSTRACT

Recurrent primary central nervous system lymphomas (PCNSL) have a very poor prognosis. For young and fit patients, intensive chemotherapy followed by autologous stem cell transplantation could be proposed at relapse. In the other cases (unfit or elderly patients), therapeutic options are limited with no consensual regimen. The poly-chemotherapy by (R)-GEMOX is associated with anti-tumor activity in systemic lymphomas and a favorable toxicity profile. Our objective was to evaluate the activity and tolerance of (R)-GEMOX in PCNSL patients enrolled in the French nation-wide LOC cohort. We retrospectively analyzed all refractory or recurrent patients included in the LOC network who benefited from (R)-GEMOX (rituximab 375 mg/m2, gemcitabine 1000 mg/m2, and oxaliplatine 100 mg/m2). Administration, tolerance, and efficacy data were analyzed. Thirteen patients, treated in five different institutions, benefited from the (R)-GEMOX regimen from February 2013 to August 2017. At the initiation of (R)-GEMOX, median age was 71.4 years old (range, 49.5-82.5) and median Karnofsky performance status (KPS) was 60 (range, 40-80). Seven patients were in second line of treatment whereas the six others were in third line or over. All patients had received methotrexate-based polychemotherapy as first-line treatment except one. Overall response rate was 38% with two complete responses and three partial responses. Median progression-free survival was 3.2 months (95%CI: 0.2-6.2), and median overall survival was 8.2 months (95%CI: 0.6-15.8). Toxicity was mainly hematological including grade ¾ neutropenia (38%), lymphopenia (23%), and thrombopenia (23%). Older age (p = 0.046) and low KPS (p = 0.054) tended to be associated with a worse prognosis. (R)-GEMOX is associated with substantial response rate and favorable toxicity profile in unfit patients with recurrent PCNSL. (R)-GEMOX could be considered to be an additional option in patients with recurrent/refractory PCNSL. More... »

PAGES

915-922

References to SciGraph publications

  • 2006-11. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors in JOURNAL OF NEURO-ONCOLOGY
  • 2005-12. Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice in BMC CANCER
  • 2009-10. Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-03. Temozolomide as salvage treatment in primary brain lymphomas in BRITISH JOURNAL OF CANCER
  • 2011-11. Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma in JOURNAL OF NEURO-ONCOLOGY
  • 2010-04. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1999-06. Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-01. Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status in JOURNAL OF NEURO-ONCOLOGY
  • 2016-01. Safety and efficacy of primary central nervous system lymphoma treatment in elderly population in NEUROLOGICAL SCIENCES
  • 2011-10. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma in BRITISH JOURNAL OF CANCER
  • 2014-03. Methotrexate re-challenge for recurrent primary central nervous system lymphoma in JOURNAL OF NEURO-ONCOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00277-018-3564-6

    DOI

    http://dx.doi.org/10.1007/s00277-018-3564-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110448613

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30535802


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Age Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Central Nervous System Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Deoxycytidine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease-Free Survival", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Recurrence, Local", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Organoplatinum Compounds", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rituximab", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival Rate", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Aix-Marseille University", 
              "id": "https://www.grid.ac/institutes/grid.5399.6", 
              "name": [
                "APHM, service de Neuro-Oncologie, Timone Hospital, CHU Timone, 264 rue saint Pierre, 13005, Marseille, France", 
                "Aix-Marseille Universit\u00e9, UMR911, Marseille, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Collignon", 
            "givenName": "A.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "APHP, UPMC Univ Paris 06, Service de neurologie Mazarin, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9s, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Houillier", 
            "givenName": "C.", 
            "id": "sg:person.01243153023.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243153023.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hopitaux Civils de Colmar", 
              "id": "https://www.grid.ac/institutes/grid.477063.1", 
              "name": [
                "Service de Neurologie, H\u00f4pitaux Civils de Colmar, Colmar, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ahle", 
            "givenName": "G.", 
            "id": "sg:person.01301262725.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301262725.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Aix-Marseille University", 
              "id": "https://www.grid.ac/institutes/grid.5399.6", 
              "name": [
                "APHM, service de Neuro-Oncologie, Timone Hospital, CHU Timone, 264 rue saint Pierre, 13005, Marseille, France", 
                "Aix-Marseille Universit\u00e9, UMR911, Marseille, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chinot", 
            "givenName": "O.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital", 
              "id": "https://www.grid.ac/institutes/grid.411439.a", 
              "name": [
                "Service d\u2019H\u00e9matologie, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Choquet", 
            "givenName": "S.", 
            "id": "sg:person.0613736762.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613736762.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institut Bergoni\u00e9", 
              "id": "https://www.grid.ac/institutes/grid.476460.7", 
              "name": [
                "Service d\u2019oncologie m\u00e9dicale, Unit\u00e9 d\u2019h\u00e9matologie, Institut Bergonie, Bordeaux, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schmitt", 
            "givenName": "A.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Unit\u00e9 d\u2019h\u00e9matologie, Centre Hospitalier D\u00e9partemental Felix Guyon, Saint Denis, La R\u00e9union, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Agape", 
            "givenName": "P.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Service d\u2019H\u00e9matologie, Institut Curie-Ren\u00e9 Huguenin, Saint-Cloud, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Soussain", 
            "givenName": "C.", 
            "id": "sg:person.01222215700.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222215700.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "APHP, UPMC Univ Paris 06, Service de neurologie Mazarin, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9s, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hoang-Xuan", 
            "givenName": "K.", 
            "id": "sg:person.01117530714.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117530714.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Aix-Marseille University", 
              "id": "https://www.grid.ac/institutes/grid.5399.6", 
              "name": [
                "APHM, service de Neuro-Oncologie, Timone Hospital, CHU Timone, 264 rue saint Pierre, 13005, Marseille, France", 
                "Aix-Marseille Universit\u00e9, UMR911, Marseille, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tabouret", 
            "givenName": "Emeline", 
            "id": "sg:person.01160514623.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160514623.82"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s002800050955", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001803904", 
              "https://doi.org/10.1007/s002800050955"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1600-0609.2007.00996.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002340333"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1600-0609.2007.00996.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002340333"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6603660", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003449325", 
              "https://doi.org/10.1038/sj.bjc.6603660"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2005.13.524", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003658256"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/blood-2013-06-453084", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005748974"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/blood-2015-10-673236", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006387439"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2006.08.2941", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010797136"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10072-015-2371-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014367188", 
              "https://doi.org/10.1007/s10072-015-2371-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10072-015-2371-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014367188", 
              "https://doi.org/10.1007/s10072-015-2371-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(15)00076-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019209751"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-014-1370-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019739839", 
              "https://doi.org/10.1007/s11060-014-1370-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-04-0159", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021593241"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/wco.0000000000000145", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022947738"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/wco.0000000000000145", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022947738"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-009-0941-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026151695", 
              "https://doi.org/10.1007/s00280-009-0941-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cncr.20339", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026362836"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.14791/btrt.2015.3.2.75", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028787040"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-006-9165-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028814652", 
              "https://doi.org/10.1007/s11060-006-9165-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2407-5-103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030206234", 
              "https://doi.org/10.1186/1471-2407-5-103"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-011-0652-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030511433", 
              "https://doi.org/10.1007/s11060-011-0652-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-009-1085-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035532021", 
              "https://doi.org/10.1007/s00280-009-1085-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-009-1085-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035532021", 
              "https://doi.org/10.1007/s00280-009-1085-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-009-1085-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035532021", 
              "https://doi.org/10.1007/s00280-009-1085-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3324/haematol.2013.090597", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037023670"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-011-0608-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038149145", 
              "https://doi.org/10.1007/s11060-011-0608-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/neuonc/nos207", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038896423"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2007.13.5533", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051914205"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.2011.357", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052077972", 
              "https://doi.org/10.1038/bjc.2011.357"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/neuonc/now033", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1059935198"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1352458508098268", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063988863"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1352458508098268", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063988863"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1352458508098268", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063988863"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2003.03.036", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064203440"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2003.09.139", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064203872"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000137050.43114.42", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064346302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000137050.43114.42", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064346302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000137050.43114.42", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064346302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000276986.19602.c1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064349586"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000276986.19602.c1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064349586"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000276986.19602.c1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064349586"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.0000000000003420", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064354111"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.0000000000003420", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064354111"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.0000000000003420", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064354111"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.0b013e318266fcb2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064357185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.0b013e318266fcb2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064357185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.0b013e318266fcb2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064357185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/wnl.54.8.1707", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064378617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-2-1-40", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064414209"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-2008-067", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064414370"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1079105597", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/neurosurgery/46.1.51", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083583727"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/blood-2017-01-764209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084249582"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/2159-8290.cd-17-0613", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1086048716"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2017.72.7602", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1086133657"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/bloodadvances.2017014845", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105435221"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/bloodadvances.2017014845", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105435221"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/bloodadvances.2017014845", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105435221"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1182/blood-2018-01-791558", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105496736"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-04", 
        "datePublishedReg": "2019-04-01", 
        "description": "Recurrent primary central nervous system lymphomas (PCNSL) have a very poor prognosis. For young and fit patients, intensive chemotherapy followed by autologous stem cell transplantation could be proposed at relapse. In the other cases (unfit or elderly patients), therapeutic options are limited with no consensual regimen. The poly-chemotherapy by (R)-GEMOX is associated with anti-tumor activity in systemic lymphomas and a favorable toxicity profile. Our objective was to evaluate the activity and tolerance of (R)-GEMOX in PCNSL patients enrolled in the French nation-wide LOC cohort. We retrospectively analyzed all refractory or recurrent patients included in the LOC network who benefited from (R)-GEMOX (rituximab 375\u00a0mg/m2, gemcitabine 1000\u00a0mg/m2, and oxaliplatine 100\u00a0mg/m2). Administration, tolerance, and efficacy data were analyzed. Thirteen patients, treated in five different institutions, benefited from the (R)-GEMOX regimen from February 2013 to August 2017. At the initiation of (R)-GEMOX, median age was 71.4\u00a0years old (range, 49.5-82.5) and median Karnofsky performance status (KPS) was 60 (range, 40-80). Seven patients were in second line of treatment whereas the six others were in third line or over. All patients had received methotrexate-based polychemotherapy as first-line treatment except one. Overall response rate was 38% with two complete responses and three partial responses. Median progression-free survival was 3.2\u00a0months (95%CI: 0.2-6.2), and median overall survival was 8.2\u00a0months (95%CI: 0.6-15.8). Toxicity was mainly hematological including grade \u00be neutropenia (38%), lymphopenia (23%), and thrombopenia (23%). Older age (p\u2009=\u20090.046) and low KPS (p\u2009=\u20090.054) tended to be associated with a worse prognosis. (R)-GEMOX is associated with substantial response rate and favorable toxicity profile in unfit patients with recurrent PCNSL. (R)-GEMOX could be considered to be an additional option in patients with recurrent/refractory PCNSL.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s00277-018-3564-6", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018247", 
            "issn": [
              "1269-3286", 
              "1279-8509"
            ], 
            "name": "Annals of Hematology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "98"
          }
        ], 
        "name": "(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study", 
        "pagination": "915-922", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "d9d8d2cd98db0a64442744214b93b56ae55951fcba9d584ca65f25a11710ff86"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30535802"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "9107334"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00277-018-3564-6"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110448613"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00277-018-3564-6", 
          "https://app.dimensions.ai/details/publication/pub.1110448613"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T13:05", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000366_0000000366/records_112054_00000000.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs00277-018-3564-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3564-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3564-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3564-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-018-3564-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    350 TRIPLES      21 PREDICATES      88 URIs      38 LITERALS      26 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00277-018-3564-6 schema:about N0d35691b04f44021b9e1e9a6dee0eeb6
    2 N0eb7de023fbe4474bfb2abd4cc9e081e
    3 N204114f7406b44479b74bcc4ecf80f9e
    4 N3052105408474a26ac28fc4242fc745a
    5 N4034e73584c643d699b1e81166152272
    6 N5ba3995806cb443e8cf1ad2b774e5b81
    7 N668b5b50579c42d996c39001ed52666e
    8 N91953dc6a5fe4c658d0c2e059602239e
    9 Na11ad54164ac4db084d6d68496581d25
    10 Na1497d7204ba4690a395e38eb4696cf6
    11 Na8fdda72383649abba6e64ddefb3f670
    12 Naef471a584204e6db5b129e7d48202dd
    13 Nb148973bce88425985e4df2c87fb8e11
    14 Nc163fdf073314e179525256552260b19
    15 Nd0cabc46b7e5429c9c8042a78d64307f
    16 Nd1e4ce68a93f4aa0b96916ac4373f0f9
    17 Ne4a2217798844d1992f02cb032547e2e
    18 anzsrc-for:11
    19 anzsrc-for:1112
    20 schema:author N6e3ae3199b554fc3a36659cb03437351
    21 schema:citation sg:pub.10.1007/s00280-009-0941-9
    22 sg:pub.10.1007/s00280-009-1085-7
    23 sg:pub.10.1007/s002800050955
    24 sg:pub.10.1007/s10072-015-2371-2
    25 sg:pub.10.1007/s11060-006-9165-6
    26 sg:pub.10.1007/s11060-011-0608-3
    27 sg:pub.10.1007/s11060-011-0652-z
    28 sg:pub.10.1007/s11060-014-1370-0
    29 sg:pub.10.1038/bjc.2011.357
    30 sg:pub.10.1038/sj.bjc.6603660
    31 sg:pub.10.1186/1471-2407-5-103
    32 https://app.dimensions.ai/details/publication/pub.1079105597
    33 https://doi.org/10.1002/cncr.20339
    34 https://doi.org/10.1016/s1470-2045(15)00076-5
    35 https://doi.org/10.1093/neuonc/nos207
    36 https://doi.org/10.1093/neuonc/now033
    37 https://doi.org/10.1093/neurosurgery/46.1.51
    38 https://doi.org/10.1097/wco.0000000000000145
    39 https://doi.org/10.1111/j.1600-0609.2007.00996.x
    40 https://doi.org/10.1158/1078-0432.ccr-04-0159
    41 https://doi.org/10.1158/2159-8290.cd-17-0613
    42 https://doi.org/10.1177/1352458508098268
    43 https://doi.org/10.1182/blood-2013-06-453084
    44 https://doi.org/10.1182/blood-2015-10-673236
    45 https://doi.org/10.1182/blood-2017-01-764209
    46 https://doi.org/10.1182/blood-2018-01-791558
    47 https://doi.org/10.1182/bloodadvances.2017014845
    48 https://doi.org/10.1200/jco.2003.03.036
    49 https://doi.org/10.1200/jco.2003.09.139
    50 https://doi.org/10.1200/jco.2005.13.524
    51 https://doi.org/10.1200/jco.2006.08.2941
    52 https://doi.org/10.1200/jco.2007.13.5533
    53 https://doi.org/10.1200/jco.2017.72.7602
    54 https://doi.org/10.1212/01.wnl.0000137050.43114.42
    55 https://doi.org/10.1212/01.wnl.0000276986.19602.c1
    56 https://doi.org/10.1212/wnl.0000000000003420
    57 https://doi.org/10.1212/wnl.0b013e318266fcb2
    58 https://doi.org/10.1212/wnl.54.8.1707
    59 https://doi.org/10.1215/15228517-2-1-40
    60 https://doi.org/10.1215/15228517-2008-067
    61 https://doi.org/10.14791/btrt.2015.3.2.75
    62 https://doi.org/10.3324/haematol.2013.090597
    63 schema:datePublished 2019-04
    64 schema:datePublishedReg 2019-04-01
    65 schema:description Recurrent primary central nervous system lymphomas (PCNSL) have a very poor prognosis. For young and fit patients, intensive chemotherapy followed by autologous stem cell transplantation could be proposed at relapse. In the other cases (unfit or elderly patients), therapeutic options are limited with no consensual regimen. The poly-chemotherapy by (R)-GEMOX is associated with anti-tumor activity in systemic lymphomas and a favorable toxicity profile. Our objective was to evaluate the activity and tolerance of (R)-GEMOX in PCNSL patients enrolled in the French nation-wide LOC cohort. We retrospectively analyzed all refractory or recurrent patients included in the LOC network who benefited from (R)-GEMOX (rituximab 375 mg/m<sup>2</sup>, gemcitabine 1000 mg/m<sup>2</sup>, and oxaliplatine 100 mg/m<sup>2</sup>). Administration, tolerance, and efficacy data were analyzed. Thirteen patients, treated in five different institutions, benefited from the (R)-GEMOX regimen from February 2013 to August 2017. At the initiation of (R)-GEMOX, median age was 71.4 years old (range, 49.5-82.5) and median Karnofsky performance status (KPS) was 60 (range, 40-80). Seven patients were in second line of treatment whereas the six others were in third line or over. All patients had received methotrexate-based polychemotherapy as first-line treatment except one. Overall response rate was 38% with two complete responses and three partial responses. Median progression-free survival was 3.2 months (95%CI: 0.2-6.2), and median overall survival was 8.2 months (95%CI: 0.6-15.8). Toxicity was mainly hematological including grade ¾ neutropenia (38%), lymphopenia (23%), and thrombopenia (23%). Older age (p = 0.046) and low KPS (p = 0.054) tended to be associated with a worse prognosis. (R)-GEMOX is associated with substantial response rate and favorable toxicity profile in unfit patients with recurrent PCNSL. (R)-GEMOX could be considered to be an additional option in patients with recurrent/refractory PCNSL.
    66 schema:genre research_article
    67 schema:inLanguage en
    68 schema:isAccessibleForFree false
    69 schema:isPartOf N0a3ac5d363f54046b6d733401dfb5b0b
    70 N9b6a005b0599468ca7619c7973c48988
    71 sg:journal.1018247
    72 schema:name (R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study
    73 schema:pagination 915-922
    74 schema:productId N0c4d672d297d4a4282c3d7f53da6bc1f
    75 N414563d3ac5b4c7e9e7d2f4b876d4d9b
    76 Naab641e9726143dab4ab2c0d5e8caf46
    77 Nba216e41964d482f863efe9644137c61
    78 Nc59dc9ba00ae48dd8b256e80c3f5cbc2
    79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110448613
    80 https://doi.org/10.1007/s00277-018-3564-6
    81 schema:sdDatePublished 2019-04-11T13:05
    82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    83 schema:sdPublisher Nc060d08c2d6747deb23fae6130c587b8
    84 schema:url https://link.springer.com/10.1007%2Fs00277-018-3564-6
    85 sgo:license sg:explorer/license/
    86 sgo:sdDataset articles
    87 rdf:type schema:ScholarlyArticle
    88 N0a3ac5d363f54046b6d733401dfb5b0b schema:volumeNumber 98
    89 rdf:type schema:PublicationVolume
    90 N0c4d672d297d4a4282c3d7f53da6bc1f schema:name doi
    91 schema:value 10.1007/s00277-018-3564-6
    92 rdf:type schema:PropertyValue
    93 N0d35691b04f44021b9e1e9a6dee0eeb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Aged
    95 rdf:type schema:DefinedTerm
    96 N0eb7de023fbe4474bfb2abd4cc9e081e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Humans
    98 rdf:type schema:DefinedTerm
    99 N140d9a0b252c40c49d4b9380b8a3dd78 schema:name Unité d’hématologie, Centre Hospitalier Départemental Felix Guyon, Saint Denis, La Réunion, France
    100 rdf:type schema:Organization
    101 N18eee6a8e3e746b496f6aae1746bd20f schema:name Service d’Hématologie, Institut Curie-René Huguenin, Saint-Cloud, France
    102 rdf:type schema:Organization
    103 N1c12e95677bf49dda750eefa627980c7 schema:affiliation N140d9a0b252c40c49d4b9380b8a3dd78
    104 schema:familyName Agape
    105 schema:givenName P.
    106 rdf:type schema:Person
    107 N1ed2f9da3f1746c3808529b118d5d797 schema:name APHP, UPMC Univ Paris 06, Service de neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Universités, Paris, France
    108 rdf:type schema:Organization
    109 N204114f7406b44479b74bcc4ecf80f9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Retrospective Studies
    111 rdf:type schema:DefinedTerm
    112 N3052105408474a26ac28fc4242fc745a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Neoplasm Recurrence, Local
    114 rdf:type schema:DefinedTerm
    115 N3b2e6300d2804c578b2a158896219734 schema:affiliation https://www.grid.ac/institutes/grid.476460.7
    116 schema:familyName Schmitt
    117 schema:givenName A.
    118 rdf:type schema:Person
    119 N4034e73584c643d699b1e81166152272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Middle Aged
    121 rdf:type schema:DefinedTerm
    122 N4051e8ce1a724e16bbb84abd88a645fa rdf:first N7262b4c144a342af9b19e4bf117a22d2
    123 rdf:rest N60a5829bd6fe4e9794a48be7cb131044
    124 N414563d3ac5b4c7e9e7d2f4b876d4d9b schema:name pubmed_id
    125 schema:value 30535802
    126 rdf:type schema:PropertyValue
    127 N57494516e36a40fca96c41f497aa4f8b rdf:first sg:person.01222215700.96
    128 rdf:rest N737659915d764d358eb78fe910772759
    129 N5ba3995806cb443e8cf1ad2b774e5b81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Lymphoma
    131 rdf:type schema:DefinedTerm
    132 N60a5829bd6fe4e9794a48be7cb131044 rdf:first sg:person.0613736762.95
    133 rdf:rest N646e3250e37745f4a9fec2ac1be3e71f
    134 N646e3250e37745f4a9fec2ac1be3e71f rdf:first N3b2e6300d2804c578b2a158896219734
    135 rdf:rest N6583b56f909841ca84f54c9bf4796f67
    136 N6583b56f909841ca84f54c9bf4796f67 rdf:first N1c12e95677bf49dda750eefa627980c7
    137 rdf:rest N57494516e36a40fca96c41f497aa4f8b
    138 N668b5b50579c42d996c39001ed52666e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Male
    140 rdf:type schema:DefinedTerm
    141 N6e3ae3199b554fc3a36659cb03437351 rdf:first N7e24ba77734c431fad8a572ab74f609c
    142 rdf:rest Nf404b3d8ee3049b4b376c876a3fbf1bb
    143 N71fd8cfc4abb4d5bbce661714537ee71 schema:name APHP, UPMC Univ Paris 06, Service de neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Universités, Paris, France
    144 rdf:type schema:Organization
    145 N7262b4c144a342af9b19e4bf117a22d2 schema:affiliation https://www.grid.ac/institutes/grid.5399.6
    146 schema:familyName Chinot
    147 schema:givenName O.
    148 rdf:type schema:Person
    149 N737659915d764d358eb78fe910772759 rdf:first sg:person.01117530714.26
    150 rdf:rest Ne04d9e068301449782f26b3070066bd3
    151 N7e24ba77734c431fad8a572ab74f609c schema:affiliation https://www.grid.ac/institutes/grid.5399.6
    152 schema:familyName Collignon
    153 schema:givenName A.
    154 rdf:type schema:Person
    155 N91953dc6a5fe4c658d0c2e059602239e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Female
    157 rdf:type schema:DefinedTerm
    158 N9a150ff6dab043b2aba84440e4c68b55 rdf:first sg:person.01301262725.50
    159 rdf:rest N4051e8ce1a724e16bbb84abd88a645fa
    160 N9b6a005b0599468ca7619c7973c48988 schema:issueNumber 4
    161 rdf:type schema:PublicationIssue
    162 Na11ad54164ac4db084d6d68496581d25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Survival Rate
    164 rdf:type schema:DefinedTerm
    165 Na1497d7204ba4690a395e38eb4696cf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Aged, 80 and over
    167 rdf:type schema:DefinedTerm
    168 Na8fdda72383649abba6e64ddefb3f670 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Deoxycytidine
    170 rdf:type schema:DefinedTerm
    171 Naab641e9726143dab4ab2c0d5e8caf46 schema:name dimensions_id
    172 schema:value pub.1110448613
    173 rdf:type schema:PropertyValue
    174 Naef471a584204e6db5b129e7d48202dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Disease-Free Survival
    176 rdf:type schema:DefinedTerm
    177 Nb148973bce88425985e4df2c87fb8e11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Rituximab
    179 rdf:type schema:DefinedTerm
    180 Nba216e41964d482f863efe9644137c61 schema:name readcube_id
    181 schema:value d9d8d2cd98db0a64442744214b93b56ae55951fcba9d584ca65f25a11710ff86
    182 rdf:type schema:PropertyValue
    183 Nc060d08c2d6747deb23fae6130c587b8 schema:name Springer Nature - SN SciGraph project
    184 rdf:type schema:Organization
    185 Nc163fdf073314e179525256552260b19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Antineoplastic Combined Chemotherapy Protocols
    187 rdf:type schema:DefinedTerm
    188 Nc59dc9ba00ae48dd8b256e80c3f5cbc2 schema:name nlm_unique_id
    189 schema:value 9107334
    190 rdf:type schema:PropertyValue
    191 Nd0cabc46b7e5429c9c8042a78d64307f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Age Factors
    193 rdf:type schema:DefinedTerm
    194 Nd1e4ce68a93f4aa0b96916ac4373f0f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Central Nervous System Neoplasms
    196 rdf:type schema:DefinedTerm
    197 Ne04d9e068301449782f26b3070066bd3 rdf:first sg:person.01160514623.82
    198 rdf:rest rdf:nil
    199 Ne4a2217798844d1992f02cb032547e2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Organoplatinum Compounds
    201 rdf:type schema:DefinedTerm
    202 Nf404b3d8ee3049b4b376c876a3fbf1bb rdf:first sg:person.01243153023.59
    203 rdf:rest N9a150ff6dab043b2aba84440e4c68b55
    204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    205 schema:name Medical and Health Sciences
    206 rdf:type schema:DefinedTerm
    207 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    208 schema:name Oncology and Carcinogenesis
    209 rdf:type schema:DefinedTerm
    210 sg:journal.1018247 schema:issn 1269-3286
    211 1279-8509
    212 schema:name Annals of Hematology
    213 rdf:type schema:Periodical
    214 sg:person.01117530714.26 schema:affiliation N1ed2f9da3f1746c3808529b118d5d797
    215 schema:familyName Hoang-Xuan
    216 schema:givenName K.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117530714.26
    218 rdf:type schema:Person
    219 sg:person.01160514623.82 schema:affiliation https://www.grid.ac/institutes/grid.5399.6
    220 schema:familyName Tabouret
    221 schema:givenName Emeline
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160514623.82
    223 rdf:type schema:Person
    224 sg:person.01222215700.96 schema:affiliation N18eee6a8e3e746b496f6aae1746bd20f
    225 schema:familyName Soussain
    226 schema:givenName C.
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222215700.96
    228 rdf:type schema:Person
    229 sg:person.01243153023.59 schema:affiliation N71fd8cfc4abb4d5bbce661714537ee71
    230 schema:familyName Houillier
    231 schema:givenName C.
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243153023.59
    233 rdf:type schema:Person
    234 sg:person.01301262725.50 schema:affiliation https://www.grid.ac/institutes/grid.477063.1
    235 schema:familyName Ahle
    236 schema:givenName G.
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301262725.50
    238 rdf:type schema:Person
    239 sg:person.0613736762.95 schema:affiliation https://www.grid.ac/institutes/grid.411439.a
    240 schema:familyName Choquet
    241 schema:givenName S.
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613736762.95
    243 rdf:type schema:Person
    244 sg:pub.10.1007/s00280-009-0941-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026151695
    245 https://doi.org/10.1007/s00280-009-0941-9
    246 rdf:type schema:CreativeWork
    247 sg:pub.10.1007/s00280-009-1085-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035532021
    248 https://doi.org/10.1007/s00280-009-1085-7
    249 rdf:type schema:CreativeWork
    250 sg:pub.10.1007/s002800050955 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001803904
    251 https://doi.org/10.1007/s002800050955
    252 rdf:type schema:CreativeWork
    253 sg:pub.10.1007/s10072-015-2371-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014367188
    254 https://doi.org/10.1007/s10072-015-2371-2
    255 rdf:type schema:CreativeWork
    256 sg:pub.10.1007/s11060-006-9165-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028814652
    257 https://doi.org/10.1007/s11060-006-9165-6
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1007/s11060-011-0608-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038149145
    260 https://doi.org/10.1007/s11060-011-0608-3
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1007/s11060-011-0652-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1030511433
    263 https://doi.org/10.1007/s11060-011-0652-z
    264 rdf:type schema:CreativeWork
    265 sg:pub.10.1007/s11060-014-1370-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019739839
    266 https://doi.org/10.1007/s11060-014-1370-0
    267 rdf:type schema:CreativeWork
    268 sg:pub.10.1038/bjc.2011.357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052077972
    269 https://doi.org/10.1038/bjc.2011.357
    270 rdf:type schema:CreativeWork
    271 sg:pub.10.1038/sj.bjc.6603660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003449325
    272 https://doi.org/10.1038/sj.bjc.6603660
    273 rdf:type schema:CreativeWork
    274 sg:pub.10.1186/1471-2407-5-103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030206234
    275 https://doi.org/10.1186/1471-2407-5-103
    276 rdf:type schema:CreativeWork
    277 https://app.dimensions.ai/details/publication/pub.1079105597 schema:CreativeWork
    278 https://doi.org/10.1002/cncr.20339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026362836
    279 rdf:type schema:CreativeWork
    280 https://doi.org/10.1016/s1470-2045(15)00076-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019209751
    281 rdf:type schema:CreativeWork
    282 https://doi.org/10.1093/neuonc/nos207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038896423
    283 rdf:type schema:CreativeWork
    284 https://doi.org/10.1093/neuonc/now033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059935198
    285 rdf:type schema:CreativeWork
    286 https://doi.org/10.1093/neurosurgery/46.1.51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083583727
    287 rdf:type schema:CreativeWork
    288 https://doi.org/10.1097/wco.0000000000000145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022947738
    289 rdf:type schema:CreativeWork
    290 https://doi.org/10.1111/j.1600-0609.2007.00996.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002340333
    291 rdf:type schema:CreativeWork
    292 https://doi.org/10.1158/1078-0432.ccr-04-0159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021593241
    293 rdf:type schema:CreativeWork
    294 https://doi.org/10.1158/2159-8290.cd-17-0613 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086048716
    295 rdf:type schema:CreativeWork
    296 https://doi.org/10.1177/1352458508098268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063988863
    297 rdf:type schema:CreativeWork
    298 https://doi.org/10.1182/blood-2013-06-453084 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005748974
    299 rdf:type schema:CreativeWork
    300 https://doi.org/10.1182/blood-2015-10-673236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006387439
    301 rdf:type schema:CreativeWork
    302 https://doi.org/10.1182/blood-2017-01-764209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084249582
    303 rdf:type schema:CreativeWork
    304 https://doi.org/10.1182/blood-2018-01-791558 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105496736
    305 rdf:type schema:CreativeWork
    306 https://doi.org/10.1182/bloodadvances.2017014845 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105435221
    307 rdf:type schema:CreativeWork
    308 https://doi.org/10.1200/jco.2003.03.036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203440
    309 rdf:type schema:CreativeWork
    310 https://doi.org/10.1200/jco.2003.09.139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203872
    311 rdf:type schema:CreativeWork
    312 https://doi.org/10.1200/jco.2005.13.524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003658256
    313 rdf:type schema:CreativeWork
    314 https://doi.org/10.1200/jco.2006.08.2941 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010797136
    315 rdf:type schema:CreativeWork
    316 https://doi.org/10.1200/jco.2007.13.5533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051914205
    317 rdf:type schema:CreativeWork
    318 https://doi.org/10.1200/jco.2017.72.7602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086133657
    319 rdf:type schema:CreativeWork
    320 https://doi.org/10.1212/01.wnl.0000137050.43114.42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346302
    321 rdf:type schema:CreativeWork
    322 https://doi.org/10.1212/01.wnl.0000276986.19602.c1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064349586
    323 rdf:type schema:CreativeWork
    324 https://doi.org/10.1212/wnl.0000000000003420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064354111
    325 rdf:type schema:CreativeWork
    326 https://doi.org/10.1212/wnl.0b013e318266fcb2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064357185
    327 rdf:type schema:CreativeWork
    328 https://doi.org/10.1212/wnl.54.8.1707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064378617
    329 rdf:type schema:CreativeWork
    330 https://doi.org/10.1215/15228517-2-1-40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414209
    331 rdf:type schema:CreativeWork
    332 https://doi.org/10.1215/15228517-2008-067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414370
    333 rdf:type schema:CreativeWork
    334 https://doi.org/10.14791/btrt.2015.3.2.75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028787040
    335 rdf:type schema:CreativeWork
    336 https://doi.org/10.3324/haematol.2013.090597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037023670
    337 rdf:type schema:CreativeWork
    338 https://www.grid.ac/institutes/grid.411439.a schema:alternateName Pitié-Salpêtrière Hospital
    339 schema:name Service d’Hématologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
    340 rdf:type schema:Organization
    341 https://www.grid.ac/institutes/grid.476460.7 schema:alternateName Institut Bergonié
    342 schema:name Service d’oncologie médicale, Unité d’hématologie, Institut Bergonie, Bordeaux, France
    343 rdf:type schema:Organization
    344 https://www.grid.ac/institutes/grid.477063.1 schema:alternateName Hopitaux Civils de Colmar
    345 schema:name Service de Neurologie, Hôpitaux Civils de Colmar, Colmar, France
    346 rdf:type schema:Organization
    347 https://www.grid.ac/institutes/grid.5399.6 schema:alternateName Aix-Marseille University
    348 schema:name APHM, service de Neuro-Oncologie, Timone Hospital, CHU Timone, 264 rue saint Pierre, 13005, Marseille, France
    349 Aix-Marseille Université, UMR911, Marseille, France
    350 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...